Quality Chemical Laboratories

What Quality Chemical Laboratories does

Quality Chemical Laboratories (QCL) is a privately held, vertically integrated Contract Development and Manufacturing Organization (CDMO) founded in 1998 by Dr. Yousry Sayed in Wilmington, North Carolina. The company serves pharmaceutical and biopharmaceutical clients ranging from virtual biotech startups to top 10-15 global pharmaceutical corporations, delivering a full spectrum of analytical and GMP manufacturing services — including raw material and compendial testing, analytical method development and validation, drug product and stability testing, impurity and elemental analysis, microbiology, biopharmaceutical analysis, formulation development, organic synthesis, and oral solid dose GMP manufacturing of clinical trial materials. Approximately 100 clients are served in a typical month, and the company's data has supported regulatory submissions to FDA and international agencies.

QCL operates from a multi-building Wilmington campus of roughly 90,000 ft² that is being expanded by an additional 110,000 ft² facility (3220 Corporate Drive) to bring total footprint to approximately 200,000 ft². The technology platform includes over 100 HPLC/UPLC systems, LC-MS, GC-MS, ICP-MS, NMR, XRPD, and 12,000 cubic feet of validated stability chambers, supporting work across all ICH storage conditions. New 2024-2025 additions include two AST GENiSYS sterile fill/finish lines with robotic isolator-barrier technology for liquid and lyophilized injectable manufacturing, plus in-house NMR and non-destructive container closure integrity testing. All operations are FDA registered, DEA registered, and cGMP compliant.

QCL makes money through professional-services, project-based contracts priced per quote against scope, turnaround, and regulatory complexity. The go-to-market is direct sales-led, augmented by participation in major industry conferences (Contract Pharma, BIO) and sponsorships of PDA, TBT, and ISPE. Clients range from preclinical through clinical trial material manufacturing stages. The company has grown organically over 25+ years without disclosed external funding and currently employs over 250 people, with a long-stated ambition to reach 500.

Name

Quality Chemical Laboratories

Legal name

Quality Chemical Laboratories, Inc.

Website

https://qualitychemlabs.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

Quality Chemical Laboratories is a privately held, FDA-registered CDMO in Wilmington, NC, providing integrated analytical testing, formulation development, GMP manufacturing, and (from 2025) sterile fill/finish services to roughly 100 pharmaceutical and biotech clients monthly, from virtual startups to top global pharma.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing and Testing (CDMO/CRO)

NAICS

Testing Laboratories and Services (541380), Scientific Research and Development Services (5417), Pharmaceutical Preparation Manufacturing (325412)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Release Testing & Batch Certification (QC) (HLAGADAC)

Keywords

• Contract pharmaceutical testing
• GMP manufacturing services
• Analytical method development
• Stability testing services
• Sterile fill finish

Headquarters

HQ city

Wilmington

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Contract Pharmaceutical Testing Services: QCL generates revenue through contract analytical testing services for pharmaceutical companies, including raw material testing, compendial testing, method development and validation, finished product analysis, stability studies, and microbiology testing. Services are priced via project quotes based on scope and turnaround requirements.
2. Contract Development and Manufacturing (CDMO): Revenue from formulation development and GMP clinical trial material manufacturing services including solid oral dosage forms (tablets, capsules, minitablets, films, gels, solutions) and sterile fill/finish manufacturing. Billing is project-based, typically tied to specific manufacturing campaigns or development milestones.
3. Rush and Priority Testing Services: QCL offers expedited/priority turnaround for compendial monograph testing upon request and with prior approval, providing a premium service tier for time-sensitive pharmaceutical development needs.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Quality Chemical Laboratories (QCL) is a full-service Contract Development and Manufacturing Organization (CDMO) providing integrated analytical testing, formulation development, and GMP clinical trial material manufacturing for pharmaceutical and biopharmaceutical companies. Services span raw material and compendial testing, analytical method development and validation, stability storage and testing, impurity analysis, microbiology, biopharmaceutical testing, organic synthesis, formulation development, oral solid dose GMP manufacturing, and (from 2025) sterile fill/finish with lyophilization.

Product overview

Quality Chemical Laboratories (QCL) operates as a full-service Contract Development and Manufacturing Organization (CDMO) founded in 1998, offering an integrated portfolio of pharmaceutical testing and manufacturing services. The core offering spans analytical services (Raw Material Testing, Analytical Development, Drug Product Analysis, Stability Testing, Impurity Analysis, and Microbiology Laboratory) combined with manufacturing capabilities (Formulation Development, GMP Manufacturing, and Organic Synthesis). The company has recently expanded into Biopharmaceutical Services and Sterile Fill/Finish Manufacturing. Services are delivered through a 90,000 ft² campus with over 100 HPLC systems and a newly constructed 110,000 ft² facility with sterile manufacturing capability, all under FDA and DEA registration.

Differentiator

Problem solved

Functional benefit

Products and services

• Raw Material Testing

Quantifiable outcome

• Routine 10-15 business day turnaround for compendial monograph testing
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Unravel Biosciences, Inc.coreStrategic or Co-development Partner · 19 March 2024QCL entered a manufacturing and development partnership with Unravel Biosciences, an AI-enabled therapeutics company developing drugs for complex diseases. QCL is manufacturing RVL001 clinical trial material for use in US and Colombia proof-of-concept clinical trials for Rett syndrome, a rare neurogenetic disorder. QCL leverages its synthetic and analytical chemistry expertise to help Unravel initiate clinical trial programs with rapid scale-up capability as the program advances.
• Parenteral Drug Association (PDA) — Southeast ChapterminorOthers · 1 January 2023QCL is an Official Sponsor of the PDA Southeast Chapter, a leading industry organization for pharmaceutical and parenteral drug professionals. Sponsorship provides visibility within the industry and alignment with key professional standards and networking platforms.
• Triangle Biotech Tuesday (TBT)minorOthers · 1 January 2023QCL is a sponsor of Triangle Biotech Tuesday, a regional biotech networking community. Sponsorship supports industry connections and visibility within the biotech ecosystem.
• International Society for Pharmaceutical Engineering (ISPE) — Port City ConnectsminorOthers · 1 January 2023QCL is a sponsor of the ISPE Port City Connects event, a professional development and networking event for pharmaceutical industry professionals in the Wilmington/Port City area.
• NOVA Thin Film Pharmaceuticals LLCcoreStrategic or Co-development Partner · 1 June 2020QCL announced a partnership with NOVA Thin Film Pharmaceuticals for the formation and commencement of soluble thin film operations. QCL provides formulation development and manufacturing capabilities for NOVA's thin film drug delivery technology, enabling the development of soluble thin film pharmaceutical products.

Scale indicators9 records

Recent moves10 records

Expansion highlights4 records

Broad incumbents

• SGS SA: Global testing, inspection, and certification company with a life sciences division offering pharmaceutical analytical, microbiological, and stability testing services comparable to QCL.
• Eurofins Scientific: Global leader in contract laboratory testing, including pharmaceutical analytical services, compendial testing, and method development. Comparable service lines to QCL's raw material and drug product testing.
• Lonza Group: Global CDMO with leading position in sterile fill/finish, oral solid dose, and biopharmaceutical services. Comparable in service breadth to QCL but at vastly greater scale.
• Catalent (Novo Holdings): One of the largest global CDMOs offering analytical, oral solid dose, sterile fill/finish, and biopharmaceutical services across all phases. QCL competes for similar clients at smaller scale.
• Charles River Laboratories: Global CRO/CDMO offering analytical testing, biologics testing, and contract manufacturing services — overlaps with QCL's biopharmaceutical services and analytical development offerings.
• Thermo Fisher Scientific (CDMO/PPD): Operates a broad CDMO and contract analytical testing business (Patheon, PPD) serving pharmaceutical and biotech clients globally. Direct overlap in analytical testing and small molecule manufacturing.

Emerging players

• Ardena: European-headquartered CDMO providing analytical, formulation development, and GMP manufacturing for early-phase programs — comparable scale and stage of clients to QCL's virtual/startup customer segment.

Direct peers

• Alcami Corporation: US-based mid-sized CDMO offering analytical testing, formulation development, and GMP manufacturing of oral solid dose and sterile drug products. Closely comparable in scale and service mix to QCL.
• Metrics Contract Services (Mayne Pharma): CDMO specializing in early-phase clinical trial material manufacturing of oral solid dose forms — a direct overlap with QCL's 6,000 ft² GMP CTM operation.
• Jubilant HollisterStier: Mid-sized CDMO offering sterile injectable manufacturing, oral solid dose, and analytical services — directly comparable to QCL's expansion into sterile fill/finish and oral solid dose.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/quality-chemical-laboratories

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quality Chemical Laboratories